🇺🇸 FDA
Patent

US 7662573

Methods for evaluating osteoarthritis risk

granted A61PA61P19/02A61P29/00

Quick answer

US patent 7662573 (Methods for evaluating osteoarthritis risk) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P19/02, A61P29/00